Chowdhury, Nupur (2013) Poor definitions threaten drug trial safety in India. Nature Medicine, 19 (1). ISSN 10788956
Text
nm0113-15-naturemedicine (1).pdf - Published Version
Restricted to Repository staff only
Download (192kB) | Request a copy
nm0113-15-naturemedicine (1).pdf - Published Version
Restricted to Repository staff only
Download (192kB) | Request a copy
Abstract
India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.
Item Type: | Article |
---|---|
Keywords: | Clinical Trials as Topic | Government Regulation | Humans | India | Medical Errors | Outsourced Services | Safety |
Subjects: | Social Sciences and humanities > Social Sciences > Human Rights |
JGU School/Centre: | Jindal Global Law School |
Depositing User: | Amees Mohammad |
Date Deposited: | 21 Feb 2022 11:09 |
Last Modified: | 21 Feb 2022 11:14 |
Official URL: | https://doi.org/10.1038/nm0113-15 |
Additional Information: | Notes |
URI: | https://pure.jgu.edu.in/id/eprint/1357 |
Downloads
Downloads per month over past year